News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The French Biopharmaceutical Group LFB S.A. Has Announced the First-in-Man Injections of Its First Two Therapeutic Monoclonal Antibodies and the Filing of BLAs for a New-Generation Immunoglobulin and a Fibrinogen


2/10/2009 10:04:33 AM

LES ULIS, France--(BUSINESS WIRE)--During Q4 2008, two monoclonal antibodies developed by LFB's R&D division (an anti-D monoclonal and a batch of anti-CD 20) both achieved a significant development milestone - first-in-man administration.

Read at BioSpace.com

comments powered by Disqus
LFB S.A.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES